309 related articles for article (PubMed ID: 29439125)
1. Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Postcontrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis.
Zivadinov R; Ramasamy DP; Hagemeier J; Kolb C; Bergsland N; Schweser F; Dwyer MG; Weinstock-Guttman B; Hojnacki D
AJNR Am J Neuroradiol; 2018 Apr; 39(4):642-647. PubMed ID: 29439125
[TBL] [Abstract][Full Text] [Related]
2. Leptomeningeal Contrast Enhancement Is Related to Focal Cortical Thinning in Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional MRI Study.
Bergsland N; Ramasamy D; Tavazzi E; Hojnacki D; Weinstock-Guttman B; Zivadinov R
AJNR Am J Neuroradiol; 2019 Apr; 40(4):620-625. PubMed ID: 30872420
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the added value of contrast-enhanced 3D fluid-attenuated inversion recovery and magnetization-prepared rapid acquisition of gradient echo sequences in relation to conventional postcontrast T1-weighted images for the evaluation of leptomeningeal diseases at 3T.
Fukuoka H; Hirai T; Okuda T; Shigematsu Y; Sasao A; Kimura E; Hirano T; Yano S; Murakami R; Yamashita Y
AJNR Am J Neuroradiol; 2010 May; 31(5):868-73. PubMed ID: 20037130
[TBL] [Abstract][Full Text] [Related]
4. Pre- and Postcontrast 3D Double Inversion Recovery Sequence in Multiple Sclerosis: A Simple and Effective MR Imaging Protocol.
Eichinger P; Kirschke JS; Hoshi MM; Zimmer C; Mühlau M; Riederer I
AJNR Am J Neuroradiol; 2017 Oct; 38(10):1941-1945. PubMed ID: 28751518
[TBL] [Abstract][Full Text] [Related]
5. Leptomeningeal Enhancement on 3D-FLAIR MRI in Multiple Sclerosis: Systematic Observations in Clinical Practice.
Titelbaum DS; Engisch R; Schwartz ED; Napoli SQ; Sloane JA; Samaan S; Katz JD; Lathi ES
J Neuroimaging; 2020 Nov; 30(6):917-929. PubMed ID: 32830899
[TBL] [Abstract][Full Text] [Related]
6. Investigation of leptomeningeal enhancement in MS: a postcontrast FLAIR MRI study.
Eisele P; Griebe M; Szabo K; Wolf ME; Alonso A; Engelhardt B; Hennerici MG; Gass A
Neurology; 2015 Feb; 84(8):770-5. PubMed ID: 25616480
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and Prediction of Relapses in Susac Syndrome: A New Use for MR Postcontrast FLAIR Leptomeningeal Enhancement.
Coulette S; Lecler A; Saragoussi E; Zuber K; Savatovsky J; Deschamps R; Gout O; Sabben C; Aboab J; Affortit A; Charbonneau F; Obadia M
AJNR Am J Neuroradiol; 2019 Jul; 40(7):1184-1190. PubMed ID: 31248864
[TBL] [Abstract][Full Text] [Related]
8. Leptomeningeal Enhancement at 7T in Multiple Sclerosis: Frequency, Morphology, and Relationship to Cortical Volume.
Harrison DM; Wang KY; Fiol J; Naunton K; Royal W; Hua J; Izbudak I
J Neuroimaging; 2017 Sep; 27(5):461-468. PubMed ID: 28464368
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal Persistence of Meningeal Enhancement on Postcontrast 7T 3D-FLAIR MRI in Multiple Sclerosis.
Jonas SN; Izbudak I; Frazier AA; Harrison DM
AJNR Am J Neuroradiol; 2018 Oct; 39(10):1799-1805. PubMed ID: 30213813
[TBL] [Abstract][Full Text] [Related]
10. Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study.
Zivadinov R; Ramasamy DP; Vaneckova M; Gandhi S; Chandra A; Hagemeier J; Bergsland N; Polak P; Benedict RH; Hojnacki D; Weinstock-Guttman B
Mult Scler; 2017 Sep; 23(10):1336-1345. PubMed ID: 27811339
[TBL] [Abstract][Full Text] [Related]
11. Comparison of post-contrast 3D-T
Jeevanandham B; Kalyanpur T; Gupta P; Cherian M
Br J Radiol; 2017 Jun; 90(1074):20160834. PubMed ID: 28375660
[TBL] [Abstract][Full Text] [Related]
12. Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging.
Mathews VP; Caldemeyer KS; Lowe MJ; Greenspan SL; Weber DM; Ulmer JL
Radiology; 1999 Apr; 211(1):257-63. PubMed ID: 10189481
[TBL] [Abstract][Full Text] [Related]
13. "Ivy sign" in childhood moyamoya disease: depiction on FLAIR and contrast-enhanced T1-weighted MR images.
Yoon HK; Shin HJ; Chang YW
Radiology; 2002 May; 223(2):384-9. PubMed ID: 11997541
[TBL] [Abstract][Full Text] [Related]
14. Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis.
Hildesheim FE; Ramasamy DP; Bergsland N; Jakimovski D; Dwyer MG; Hojnacki D; Lizarraga AA; Kolb C; Eckert S; Weinstock-Guttman B; Zivadinov R
Mult Scler Relat Disord; 2021 Jan; 47():102653. PubMed ID: 33333417
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of Contrast-Enhanced 3D-FLAIR MR Imaging for Differentiating Rathke Cleft Cyst from Cystic Craniopharyngioma.
Azuma M; Khant ZA; Kitajima M; Uetani H; Watanabe T; Yokogami K; Takeshima H; Hirai T
AJNR Am J Neuroradiol; 2020 Jan; 41(1):106-110. PubMed ID: 31857323
[TBL] [Abstract][Full Text] [Related]
16. Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis.
Absinta M; Vuolo L; Rao A; Nair G; Sati P; Cortese IC; Ohayon J; Fenton K; Reyes-Mantilla MI; Maric D; Calabresi PA; Butman JA; Pardo CA; Reich DS
Neurology; 2015 Jul; 85(1):18-28. PubMed ID: 25888557
[TBL] [Abstract][Full Text] [Related]
17. Improving Detection of Multiple Sclerosis Lesions in the Posterior Fossa Using an Optimized 3D-FLAIR Sequence at 3T.
Lecler A; El Sanharawi I; El Methni J; Gout O; Koskas P; Savatovsky J
AJNR Am J Neuroradiol; 2019 Jul; 40(7):1170-1176. PubMed ID: 31248862
[TBL] [Abstract][Full Text] [Related]
18. Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance.
Harrison DM; Allette YM; Zeng Y; Cohen A; Dahal S; Choi S; Zhuo J; Hua J
PLoS One; 2024; 19(5):e0300298. PubMed ID: 38809920
[TBL] [Abstract][Full Text] [Related]
19. Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases.
Absinta M; Cortese IC; Vuolo L; Nair G; de Alwis MP; Ohayon J; Meani A; Martinelli V; Scotti R; Falini A; Smith BR; Nath A; Jacobson S; Filippi M; Reich DS
Neurology; 2017 Apr; 88(15):1439-1444. PubMed ID: 28283598
[TBL] [Abstract][Full Text] [Related]
20. Susac's syndrome: Leptomeningeal enhancement on 3D FLAIR MRI.
Engisch R; Titelbaum DS; Chilver-Stainer L; Kellner-Weldon F
Mult Scler; 2016 Jun; 22(7):972-4. PubMed ID: 27207452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
